clentiazem has been researched along with Aortic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwasaki, H; Morita, T; Odawara, A; Ohtani, A; Saso, Y; Takashima, K | 1 |
| Bendayan, M; Bouthillier, D; Garceau, D; Garofalo, C; Lavigne, F; Levy, E; Russo, P; St-Louis, J; Tardif, J; Thibault, L | 1 |
2 other study(ies) available for clentiazem and Aortic Diseases
| Article | Year |
|---|---|
Inhibitory effect of clentiazem (TA-3090), a new calcium antagonist, on balloon catheter-induced intimal thickening of rabbit aorta.
Topics: Animals; Aortic Diseases; Arteriosclerosis; Calcium Channel Blockers; Catheterization; Cell Division; Cells, Cultured; Collagen; Diet, Atherogenic; Diltiazem; Disease Models, Animal; Lipids; Male; Muscle, Smooth, Vascular; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits | 1993 |
Effect of clentiazem on lipid profile, lipoprotein composition and aortic fatty streaks in cholesterol-fed rabbits.
Topics: Animals; Antihypertensive Agents; Aorta; Aortic Diseases; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Diltiazem; Lipid Metabolism; Lipids; Lipoproteins; Male; Rabbits; Triglycerides | 1991 |